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PL-004 Investigation of the wide spectra of biologic
activities of immunomodulators with a new
complex model in vivo
T. Karatzuba1 *, L. Bondarenko1, V. Kovalenko1. 1SI
“Institute of Pharmacology & Toxicology” National
Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
Objectives: Optimization of drugs use could be achieved
only at full understanding of their speciﬁc pharmacological
effects in human organism. Our aim was to investigate
wide spectra of biologic activities of immunomodulators
Epobiocrin (Epoetin alfa, Biopharma, Ukraine) and
Neupogen (Filgrastimum, Roche, Switzerland) with new
complex model of neutropenia and anemia in vivo.
Methods: Albino female mice were divided into four
groups. Animals of groups I-III received vincristine sulfate
intraperitoneally at a dose of 0.52mg/kg b.w./day, twice,
at 1 and 8 days of experiment (for neutropenia and
anemia modelling). Among this, mice from group II
received subcutaneously Epobiocrin 3780 IU/kg b.w./day
8 injections with 48 hour intervals, mice from group III
received subcutaneously Neupogen 0.126mg/kg b.w./day
14 injections with 24 hour intervals. The positive control
group (IV) was composed of intact animals. At 15 day
of experiment animals were sacriﬁced and their blood
and spleens were investigated. Hematological studies
were carried out with hematological analyzer MYTHIC 22
(C2Diagnostics, France).
Results: As a result of our experiments was created
new complex model of neutropenia and anemia with use
of vincristine sulfate in dose of 1/10 LD50, which was
inferior to none of previously used models in respect of
pathologic changes rates and their statistic signiﬁcance. Its
positive advantages were lower quantity of preparation
and possibility to regulate required levels of pathology
manifestation. With our combined model of anemia and
neutropenia both Epobiocrin and Neupogen demonstrated
ability to stimulate erythropoiesis (increase of erythrocytes
number, hemoglobin level, spleen mass coefﬁcient) and
leukopoiesis (increase of neutrophils level) in comparison
with group I.
Conclusion: Thus use of our model allowed to demonstrate
that preparations are regulators both erythropoiesis and
leukopoiesis which must be taken into account in medicine
at immunocorrection treatment.
OL-025 Expression of insulin-like growth factor-I
receptor and its clinical pathological
characteristics in human hepatocellular
carcinoma
N.H. Yao1 *, D.F. Yao1, D.D. Yu1, W. Wu1. 1Research
Center of Clinical Medicine, Afﬁliated Hospital of Nantong
University, Nantong 226001, Jiangsu Province, China
Background: Insulin-like growth factor-I receptor (IGF-IR)
which highly expression in the embryonic period in vivo
and Maintain a low concentration levels in adulthood. As an
important mediated factor IGF-IR take part in the regulation
of cell growth, differentiation and proliferation. It also
mediates mitogen signal, anti-apoptotic, induce vascular
endothelial growth factor (VEGF) and necessity for cell
type transformation. We investigated the expression and
its clinical pathological alteration of IGF-IR in different
parts of human hepatocellular carcinoma (HCC) and its
paracancerous tissues.
Methods: Using the immunohistochemistry and nested-PCR
assay, IGF-IR and IGF-1R gene expression was detected in
30 HCC and their non-cancerous tissues. The relationship
between IGF-IR and IGF-II or their clinical pathological
characteristics was investigated.
Results: The stronger expression of IGF-IR was found in
either HCC or non-cancerous tissues. The positive rate of
IGF-IR expression was 80.0% in HCC tissues, and 43.3% in
non-cancerous tissues, respectively. A signiﬁcant difference
was present between them (c2 = 8.53, P < 0.01). The positive
expression of IGF-IR in HCC was correlated to tumor
differentiation, but not to tumor number, size, HBsAg and
AFP. The expressions of IGF-IR and IGF-II in HCC were
of positive correlation. The level of IGF-IR expression
was positively correlated with the corresponding degree
of differentiation for which the incidence was 44.4% in
the high differentiation group, 92.9% in the moderate
differentiation, and 100% in the low differentiation group
(Fisher’s exact test). The IGF-IR and IGF-II expressed of
moderate and low differentiation of HCC are more than high
differentiation ones signiﬁcantly, and they also had positive
correlation in different degree of differentiation (P < 0.05).
Conclusion: The overexpression of hepatic IGF-IR was
associated with the occurrence and development of HCC.
OL-026 Dickkopf-1 down-regulates transforming
growth factor-b1 induced hepatic stellate cells
activation
W.T. Li1 *, Z.H. Xiao2, C.L. Zhu1, Y. Li1, R.T. Gao1.
1Department of Infectious Disease, Anhui Provincial
Hospital, Anhui Medical University, 2Department of
Biochemistry, Tongji Medical College, The Huazhong
University of Sciences and Technology, China
Background: It has been demonstrated that TGF-b1 played
a key role in HSCs activation through interaction with b-
catenin. This study was designed to elucidate the molecular
mechanism involved in the effect of inhibition of b-catenin
on TGF-b1 induced HSCs activation.
Methods: HSC-T6 cells were transfected with pEGFP-C1-
Dickkopf-1 (DKK-1, experiment group) and pEGFP-C1-neo
(control group), while the normal group received PBS
instead of DKK-1. All cells without the normal group were
incubated with 1 ng/ml TGF-b1 for 2 hours. At the end of
the experiment, the mRNA and protein levels of smad3,
b-catenin and a-SMA in cells were analyzed via RT-PCR and
western-blot.
Results: Both mRNA and protein levels of b-catenin and
a-SMA in HSCs were signiﬁcantly increased by TGF-b1
in control group compared with normal group, whereas
DKK-1 markedly reduced all the above parameters (p < 0.05,
respectively). Moreover, DKK-1 signiﬁcantly decreased the
cell viability of HSC-T6 cells compared with control group.
Figure 1. Transfection of DKK-1.
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Figure 2. DKK-1 reduced the cell viability of HSC-T6 cells.
Conclusions: Inhibition of Wnt/b-catenin pathway down-
regulated the TGF-b1-induced activation of HSCs, which
might provide us a new therapeutic approach to liver
ﬁbrosis.
OL-027 Changes in expression of renal Oat1, Oat3 and
Mrp2 in ANIT-induced cholestatic hepatitis in
rat after treatment of JBP485
T. Liu1 *, Q. Meng1, C.Y. Wang1, Q. Liu1, X.J. Guo1,
K.X. Liu1. 1Department of Clinical Pharmacology, College
of Pharmacy, Dalian Medical University, China
Background: To investigate the protective effects of JBP485
(cyclo-trans-4-l-hydroxyprolyl-l-serine, a dipeptide with
anti-inﬂammatory action) on alpha-naphthylisothiocyanate
(ANIT)-induced cholestatic hepatitis and whether these are
mediated by the organic anion transporters Oat1 and Oat3
and the multidrug resistance-associated protein Mrp2.
Methods: The effects of JBP485 on ANIT-induced liver
histologic changes, bilirubin (BIL), alanine amiotransferase
(ALT), aspartate transaminase (AST), malondialdehyde
(MDA), superoxide dismutase (SOD) and myeloperoxidase
(MPO) levels were examined. Plasma concentration and
cumulative urinary excretion of JBP485 by intravenous
administration in vivo, the uptake of JBP485 in kidney slices
in vitro were determined by LC-MS-MS. RT-PCR were used
for determine Oat1, Oat3 and Mrp2 mRNA.
Result: (1) JBP485 decreased BIL, ALT, AST, MDA and MPO
levels signiﬁcantly, alleviated inﬂammation and necrosis
in liver histochemistry in ANIT-treated rats. (2) The
plasma concentration of JBP485 was signiﬁcantly increased,
cumulative urinary excretion of JBP485 and the uptake of
JBP485 in kidney slices were decreased remarkably. (3) RT-
PCR showed the decrease in mRNA of Oat1 and Oat3 in
ANIT-treated rats, whereas, the mRNA levels of Oat1, Oat3
and Mrp2 were up-regulated with a concomitant increase
in urinary BIL after treatment with JBP485 in ANIT-treated
rats.
Conclusion: JBP485 improved liver inﬂammation condition
induced by ANIT. The mechanism is related to decrease the
inﬂammatory mediators release and improvement of the
expression and function for Oat1, Oat3 and Mrp2 as well
as facilitation of urinary excretion for hepatoxic substance.
JBP485 might be a good candidate for a new therapeutic
agent for cholestatic hepatitis.
OL-028 Study on the protective effects of mesenchymal
stem cells on ischemic reperfusion injury of
intestine in rats
H.-L. Song1, J. Zhang1 *, Z.-Y. Shen1, W.-P. Zheng1. 1Tianjin
First Center Hospital, China
Background: To study the effects of bone marrow
mesenchymal stem cells (BM MSCs) allograft on the recovery
of ischemic reperfusion injury and tight junction of intestine
in rats.
Methods: (1) BM MSCs were isolated from femur of male
Wistar rats by the density gradient centrifugation, the third
generation cultured cells were prepared as suspension.
(2) Intestinal ischemic reperfusion injury models were
established in male Wistar rats, which were divided
into the experimental group (1ml BM MSCs suspention
was injected into the intestinal submucosa) and the
control group (1ml saline was inject into the intestinal
submucosa). Then, serum and intestinal tissue samples
were collected at different time after injection, which
were analyzed by luciferase tracing, immunohistochemistry,
ELISA, transmission electron microscope and Western Blot.
Results: BM MSCs were isolated and cultured successfully
with high purity and homogeneity, and intestinal ischemic
reperfusion injury models were established successfully.
Submucosal injected BM MSCs were colonized in the
intestine and survived long-term. BM MSCs relived the
damage of intestinal villi structure under light microscope
and restored the destruction of intestinal villi and tight
junction under transmission electron microscope. Diamine
oxidase (DAO) and D-lactate were tested by ELISA. The DAO
and D-lactate in the experimental group at 6 h and 24 h
are lower than those of the control group (P < 0.05), which
showed that BM MSCs could decrease the DAO and D-lactate.
BM MSCs could decreased the expression of tumor necrosis
factor (TNF-a) at 6 h, 24 h and 72 h after injection. BM MSCs
could also promote the synthesis of ZO-1 protein tested by
Western Blot, which was time-dependant.
Conclusion: Intestinal injected BM MSCs could promote both
the expression of tight junction protein and the recovery
of intestinal ischemic reperfusion injury in rats, in which
TNF-a may play some role.
OL-029 Effects of Cornel iridoid glycoside on
apoptosis-related factors in hippocampus of
global ischemic gerbils
X.L. Li1,2 *, W. Wang2, L. Zhang2, H.X. Ai2, L. Li2 *. 1The
3rd afﬁliated hospital to Beijing University of Chinese
Medicine, 2Department of Pharmacology, Xuanwu Hospital
of Capital Medical University, China
Objective: To investigate the effects of Cornel iridoid
glycoside (CIG) on apoptotic neurons and the expression of
B cell lymphoma/leukernia-2 (Bcl-2) and Cystein-Asparate
Protease-3 (Caspase-3) in hippocampus CA1 area after global
ischemia in gerbils.
Methods: The global brain ischemic model was made by
occluding common carotid arteries for 5 min in gerbils.
One week after ischemia, the apoptotic neurons were
detected in hippocampal CA1 area by TUNEL method.
The expression of Bcl-2 and Caspase-3 was detected by
immunocytochemical method.
Results: Intragastrical administration of CIG signiﬁcantly
decreased the number of apoptotic neurons in hippocampal
CA1 area, inhibited the expression of caspase-3 and
increased Bcl-2 expression.
Conclusions: CIG can protect neurons against apoptosis
induced by cerebral ischemia.
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